… Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of …
for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group …

… To determine whether changes in objective response … prospective cohort of 283 patients with
chronic graft-versus-host disease … Overall and organ-specific responses were calculated by …

… response in clinical trials poses a major obstacle for the development of new agents in
chronic graft-… address several objectives for response criteria to be used in chronic GVHD-related …

… Overall survival or survival to permanent resolution of chronic graft-versus-host disease (…
that are accepted as measures of meaningful benefit in chronic GVHD clinical trials 1, 2, 3, but …

Chronic graft-versus-host disease (cGvHD) is a severe complication of allogeneic hematopoietic
stem cell transplantation that affects various organs leading to a reduced quality of life. …

… This report describes the rationale, design, and methods of the Chronic GVHD Response
Measures Validation Study, and invites other investigators to collaborate with the Consortium …

Chronic graft versus host disease (GVHD) is a major cause of morbidity and mortality after
allogeneic hematopoietic cell transplantation. Clinically, chronic GVHD is a pleiotropic, …

… duration of response. We determined a dominant response, which was defined as the
individual patient’s most frequent response during ECP treatment or the response leading to …

Chronic graft‐versus‐host disease (cGVHD) is a common complication following allogeneic
haematopoietic cell transplantation (HCT). It is the leading cause of non‐relapse mortality in …

… measures, clinician-reported response, and patient-reported response, we tested their
ability to predict subsequent overall survival (OS), nonrelapse mortality (NRM), and failure-free …